Broadcom (BRCM) (PTX) (APOL) (ASTM) (BPI) (CAVM) (CPLA) (EQT) (PMCS) Get New Coverage

Broadcom Corp. (NASDAQ: BRCM), Pernix Therapeutics Holdings Inc. (NYSE: PTX), Apollo Group, Inc. (NASDAQ: APOL), Aastrom Biosciences Inc. (NASDAQ: ASTM), Bridgepoint Education Inc (NYSE: BPI), Cavium Networks, Inc. (NASDAQ: CAVM), Capella Education (NASDAQ: CPLA), EQT Corp. (NYSE: EQT) and PMC-Sierra, Inc. (NASDAQ: PMCS) gettting new analyst coverage.

Stifel Nicolaus initiated coverage on Pernix Therapeutics Holdings Inc (PTX). They placed a “Buy” rating and a price target of $15.00 on the company.

Wunderlich initiated coverage on Apollo Group, Inc. (APOL). They placed a “Hold” rating and a price target of $49.00 on the company.

Global Hunter Securities initiated coverage on Aastrom Biosciences Inc. (ASTM). They placed a “Buy” rating and a price target of $6.00

on the company.

Wunderlich initiated coverage on Bridgepoint Education Inc. (BPI). They placed a “Buy” rating and a price target of $31.00 on the company.

William Blair initiated coverage on Broadcom Corporation (BRCM). They placed a “Market Perform” rating on the company.

Wunderlich initiated coverage on Cavium Networks, Inc. (CAVM). They placed a “Hold” rating and a price target of $30.00 on the company.

Wunderlich initiated coverage on Capella Education (CPLA). They placed a “Hold” rating and a price target of $37.00 on the company.

Brean Murray initiated coverage on EQT Corp. (EQT). They placed a “Buy” rating and a price target of $68.00 on the company.

Wunderlich initiated coverage on PMC-Sierra, Inc. (PMCS). They placed a “Buy” rating and a price target of $10.00 on the company.

Coverage on (ONCY) (OPTR) (SD) (PMCS) (POT) Initiated

Coverage on Oncolytics Biotech, Inc. (NASDAQ: ONCY), Optimer Pharmaceutic (NASDAQ: OPTR), SandRidge Energy Inc. (NYSE: SD), PMC-Sierra, Inc. (NASDAQ: PMCS) and Potash Corp (NYSE: POT) was initiated by analysts.

Robert W. Baird initiated coverage on SandRidge Energy Inc. (SD). They placed a “neutral” rating and a price target of $12.00 on the company.

Oppenheimer analysts initiated coverage on Oncolytics Biotech, Inc. (ONCY). They placed a “perform” rating on the company.

ThinkEquity initiated coverage on Optimer Pharmaceutic (OPTR). They placed a “buy” rating and a price target of $18.00 on the company.

Auriga initiated coverage on PMC-Sierra, Inc. (PMCS). They placed a “hold” rating and a price target of $8.00 on the company.

Macquarie initiated coverage on Potash Corp (POT). They placed an “outperform” rating and a price target of $62.00 on the company.

Coverage on (ONCY) (OPTR) (SD) (PMCS) (POT) Initiated

Coverage on Oncolytics Biotech, Inc. (NASDAQ: ONCY), Optimer Pharmaceutic (NASDAQ: OPTR), SandRidge Energy Inc. (NYSE: SD), PMC-Sierra, Inc. (NASDAQ: PMCS) and Potash Corp (NYSE: POT) was initiated by analysts.

Robert W. Baird initiated coverage on SandRidge Energy Inc. (SD). They placed a “neutral” rating and a price target of $12.00 on the company.

Oppenheimer analysts initiated coverage on Oncolytics Biotech, Inc. (ONCY). They placed a “perform” rating on the company.

ThinkEquity initiated coverage on Optimer Pharmaceutic (OPTR). They placed a “buy” rating and a price target of $18.00 on the company.

Auriga initiated coverage on PMC-Sierra, Inc. (PMCS). They placed a “hold” rating and a price target of $8.00 on the company.

Macquarie initiated coverage on Potash Corp (POT). They placed an “outperform” rating and a price target of $62.00 on the company.